As of 2025-11-04, the EV/EBITDA ratio of Intra-Cellular Therapies Inc (ITCI) is -118.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ITCI's latest enterprise value is 13,739.84 mil USD. ITCI's TTM EBITDA according to its financial statements is -116.21 mil USD. Dividing these 2 quantities gives us the above ITCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 15.4x | 11.6x |
| Forward P/E multiples | 13.1x - 16.1x | 15.6x |
| Fair Price | (11.39) - (13.94) | (11.96) |
| Upside | -108.6% - -110.6% | -109.1% |
| Date | EV/EBITDA |